Brief: Kane Biotech Announces Departure Of CEO
11/09/2018 21:42
Sept 11 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES DEPARTURE OF CEO
* KANE BIOTECH INC - MARK AHRENS-TOWNSEND HAS DEPARTED FROM
COMPANY AS CHIEF EXECUTIVE OFFICER AS OF SEPT 10, 2018
* KANE BIOTECH INC - MARK AHRENS-TOWNSEND WILL REMAIN CLOSE
TO
COMPANY AND CONTINUE TO WORK AS AN ADVISOR
* KANE BIOTECH INC - MARC EDWARDS, DIRECTOR OF KANE BIOTECH,
IS
APPOINTED AS INTERIM CEO IN ADDITION TO HIS CURRENT POSITION
Source text for Eikon: ID:nGNX1rq49n
Further company coverage: KNE.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update